基本信息
浏览量:0
职业迁徙
个人简介
Dr. Blute has had a major interest in urologic oncology and is well-known in the field of academic urology. His major areas of interest include prostate cancer, nephron-sparing surgery for kidney masses and the management of complex renal cell and bladder neoplasms. He has been involved in phase III trials of Finasteride, chemoprevention of prostatic intraepithelial neoplasia with anti-androgens, minimally invasive surgery for BPH, biomarkers in prostate cancer, and discovery of B7 family of “Check Point Inhibitor” Biomarkers in kidney cancer.
He serves as a reviewer on 13 editorial boards. He also serves on the AUA Renal Mass Guideline Panel and the American Joint Committee on Cancer. He was the recipient of the 2010 AUA Career Contribution Award. His bibliography includes 387 peer-reviewed publications, one book and 26 book chapters.
研究兴趣
论文共 294 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Edouard Nicaise,Adam S. Feldman,Andrew Gusev,Alice Yu, Naren Nimmagadda,Matthew F. Wszolek,Francis McGovern,Michael L. Blute,Douglas M. Dahl
BMC Urologyno. 1 (2024): 1-9
Timothy J. Roth,Yuri Sheinin,Christine M. Lohse, Susan M. Kuntz, Xavier Frigola,Brant A. Inman,Amy E. Krambeck, Maureen E. Mckenney,R. Jeffrey Karnes,Michael L. Blute,John C. Cheville,Thomas J. Sebo,
crossref(2023)
The Journal of urologyno. 6 (2023): 1112-1119
Urologic Clinics of North Americano. 2 (2023): i-i
Urologic Oncology: Seminars and Original Investigationsno. 2 (2022): 59.e1-59.e5
Shulin Wu,Sharron X. Lin, Gregory J. Wirth, Alexander O. Subtelny,Min Lu,Jian Lu,Zongwei Wang,Aria F. Olumi,Douglas M. Dahl,Michael L. Blute,Chin-Lee Wu
Journal of Clinical and Translational Pathologyno. 000 (2022): 000-000
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn